Page 33 of 72Results 321 to 330 of 717, 02 April - 28 June 2021
-
Governments hail progress on transformational Aberdeen BioHub
£40m project will make Aberdeen "one of the UK's most dynamic life sciences locations"
-
Scientists develop 'game-changing' antibody test
Antibody tests that can detect whether people have been exposed to new variants of Covid-19 have been developed by the University of Aberdeen, in collaboration with biotechnology group Vertebrate Antibodies Ltd and NHS Grampian.
-
Brainfood: Researchers find brain area associated with protein cravings
New research from scientists at the Universities of Aberdeen, Leicester and UiT, The Arctic University of Norway, has identified an area of the brain that may drive cravings for protein-rich food.
-
University appoints new Director of the Rowett Institute
The University of Aberdeen has appointed Professor Julian Griffin as the new Director of the Rowett Institute.
-
Covid vaccine linked to low platelet count, nationwide study suggests
A condition that affects the blood, known as idiopathic thrombocytopenic purpura (ITP), may be associated with the Oxford-AstraZeneca vaccine in rare cases, research suggests.
-
Fellowship award for Professor Lurie
Professor David Lurie has been awarded Senior Fellowship of the International Society for Magnetic Resonance in Medicine.
-
"Game-changing" technology to improve Covid-19 face mask protection
Scientists at the University of Aberdeen are using a "game-changing" technology as they aim to produce a new type of face mask that is more effective in stopping the spread of Covid-19.
-
Better Health and Social Care for Homeless People - A Reflexive Mapping Exercise
We are pleased to announce that Dr Ekta Gupta of the Institute of Dentistry, University of Aberdeen, has led a collaborative report with colleagues at the University of Dundee on the Aberdeen mapping of services addressing homelessness.
-
Covid's impact on funerals, the bereaved and funeral workers to be examined
The impact of the Covid-19 pandemic on funerals is the subject of a new study by the University of Aberdeen.
-
Aberdeen first in UK to recruit for new Huntington's disease trial
Aberdeen has recruited the first UK patient for a new trial investigating pridopidine, an oral drug for the treatment of Huntington's disease.